13/08/2025
How can support ethical decision-making when investigational drugs are used outside of clinical trials? In this episode of PHRP Perspectives, longtime FDA and HHS leader Richard Klein and NYU medical ethics expert Lisa Kearns explore the role of IRBs in treatment use, the differences between expanded access and Right to Try, and how informed consent protects patient rights.🎧 Listen to the full episode: https://bit.ly/40Nl1Dl